OHLCX Market Research
Delayed

XBI

XBI, or SPDR S&P Biotech ETF, is an exchange-traded fund (ETF) that aims to provide investment results that correspond to the performance of the S&P Biotechnology Select Industry Index. It focuses on biotechnology companies and provides exposure to a broad range of firms within the biotech sector.

−3.13 (−2.17%) Nov 20, 2026 19:55 ET Delayed
Open
143.00
High
145.50
Low
139.87
Prev close
144.12
Volume
8M
Avg vol 10
8M

Today · Market closed · opens Mon 9:30 AM

Price

XBI chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 140.99

Strong sellNeutralStrong buy
Sell
score −0.22 · 18 signalling
4Buy
6Neutral
8Sell

Leaning sell. 8 of 18 signals point down against 4 up, carried by momentum and trend. Volatility leans buy. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 15).

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −2.50 · Signal −1.21 · Hist −1.29
Sell
ADX 14
Weak trend, −DI ahead
ADX 15.28 · +DI 15.06 · −DI 28.63
Neutral
Parabolic SAR 0.02, 0.2
Above price, 12.67 over the close
153.66
Sell
Ichimoku 9, 26, 52
Price below cloud, conversion below base
Conv 148.86 · Base 150.08 · A 152.67 · B 157.57
Sell

Momentum

RSI 14
Below midpoint, not oversold
36.14
Neutral
Stoch 14, 3
Oversold, %K still below %D
%K 5.76 · %D 7.37
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K level with %D
%K 0.00 · %D 0.00
Neutral
Williams %R 14
Oversold zone, still rising
−94.24
Buy
CCI 14
Below −100, still falling
−144.27
Neutral
MFI 14
Below midpoint, not oversold
35.92
Neutral
ROC 12
Price down 11.38% over 12 bars
−11.38%
Sell
AO 5, 35
Below zero and falling
−5.51
Sell
TRIX 18
Below zero
−0.084
Sell
KST 10/15/20/30, 3
Below its signal line
KST −20.64 · Signal −14.42
Sell

Volatility

Bollinger 20, 2
Below the lower band
Up 162.03 · Mid 151.73 · Low 141.44
Buy
Keltner 20, 10, 1.5
Below the lower channel
Up 157.17 · Mid 149.72 · Low 142.27
Buy

Volume

VWAP 345-bar
Close 10.9% above VWAP
127.11
Buy
Force Index 1
Negative, sellers in control
−29.5M
Sell
ATR
4.92
3.49% of close
A/D Line
170.2M
cumulative
OBV
324.1M
cumulative
Volume Profile
121.03 – 127.14
POC · bull 416.8M · bear 373.4M · 53 / 47
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-7.56%

Change in value over the past month.

3 month return

-14.61%

Change in value over the last three months.

Max drawdown

17.32%

Largest fall from a peak to the low that followed.

Standard deviation

31.14%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.67

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.21

Annualised return against the maximum drawdown.

About

XBI summary

Loading summary…

Questions

XBI, answered

How can I invest in XBI?

Investors can purchase shares of XBI through a brokerage account. It is traded on major stock exchanges under the ticker symbol "XBI" and can be bought and sold like other stocks and ETFs.

How does XBI handle index rebalancing or changes?

XBI adjusts its holdings to reflect changes in the S&P Biotechnology Select Industry Index. The ETF rebalances periodically to ensure it continues to accurately track the index, incorporating any changes in index composition or weighting.

What factors can affect the performance of XBI?

Factors influencing XBI’s performance include biotech industry trends, regulatory changes, clinical trial outcomes, market sentiment, and broader economic conditions. The ETF’s performance is also affected by the performance of the underlying index.

What is the historical performance of XBI?

Historical performance data for XBI includes past returns, NAV, and volatility. Investors can review performance charts and reports to assess how XBI has tracked its index and how its value has changed over time.

What are the key performance metrics for XBI?

Key performance metrics for XBI include its net asset value (NAV), expense ratio, average daily trading volume, and total return over various periods (e.g., 1-year, 5-year). NAV reflects the per-share value of the ETF, while total return measures the performance of the fund.

Can XBI be used in a retirement account?

Yes, XBI can be held in retirement accounts such as IRAs or 401(k)s. It is important to consider how it fits within your overall investment strategy and risk tolerance given its focus on the biotech sector.

How often does XBI distribute dividends?

XBI typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF.

How is XBI managed?

XBI is managed by State Street Global Advisors and tracks the S&P Biotechnology Select Industry Index. The ETF is passively managed, meaning it seeks to replicate the performance of the index by holding the same securities in similar proportions.

What are the risks associated with investing in XBI?

Risks include high volatility and sector-specific risks associated with biotechnology companies. The biotech sector can be highly sensitive to regulatory changes, clinical trial results, and market sentiment, which can lead to significant fluctuations in XBI’s value.

What is the expense ratio of XBI?

XBI has an expense ratio of approximately 0.35%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

News

XBI in the news

Unlock Your XBI Trading Now

Take control of your trading with ohlcx.com. Our platform offers unparalleled analysis and technical support for XBI, designed to enhance your market performance. Start optimizing your trades today and experience the difference with our expert tools!

Maximize Results Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.